UBS Group »

Atara Biotherapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Atara Biotherapeutics (ATRA) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Atara Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atara Biotherapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atara Biotherapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $248k 17k 14.33
2025-06-30 $65k 8.4k 7.72
2025-03-31 $145k 24k 5.94
2024-12-31 $11k 834 13.31
2024-09-30 $3.3k 402 8.13
2024-06-30 $3.4k 403 8.50